Summary of product characteristics and package leaflet to be updated after the establishment of DKMA

05 November 2015, Updated 03 February 2016

Following the establishment of the Danish Medicines Agency (DKMA) on 8 October 2015, the section on the reporting of side effects must be updated in the summary of product characteristics (section 4.8) and the package leaflet (section 4) so that it says the Danish Medicines Agency and dkma@dkma.dk in the section about reporting of side effects. This applies to human medicinal products.

As regards submitted applications concerning changes to section 4 and/or 5 of the summary of product characteristics, we will change the above information about name and email in the summary of product characteristics in connection with the authorisation of the changes applied for.

We have fixed a transitional period of 3 years from 8 October 2015.We encourage marketing authorisation holders (MAH) to include the change when applying for other changes to the product information, but if the change is not included in the variation application, we will make sure that the information is updated in the summary of product characteristics.

 Alternatively, you can apply for the change as a C.I.Z, type IA variation.

The MAH can make the change to the package leaflet in connection with the next or a future revision of the package leaflet. However, it is important that patients are familiar with the methods for and the correct way of reporting suspected adverse reactions.

Section 4.8 of the summary of product characteristics

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Doctors and healthcare professionals are asked to report any suspected adverse reactions via:

Danish Medicines Agency
Axel Heides Gade 1
DK-2300 Copenhagen S
Website: www.meldenbivirkning.dk
Email: dkma@dkma.dk

Section 4 of the package leaflet

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacy. This includes any possible side effects not listed in the package leaflet. You or your relatives can also report side effects directly to the Danish Medicines Agency via the below information.

Danish Medicines Agency
Axel Heides Gade 1
DK-2300 Copenhagen S
Website: www.meldenbivirkning.dk
Email: dkma@dkma.dk

By reporting side effects, you contribute to providing more information about the safety of this medicinal product.

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.